Original blog link: https://www.newphaseblends.com/cbdv-vs-cbd/
There are some slight differences when it comes to CBDV vs CBD. While CBD remains at the forefront of most new cannabis research, CBDV follows right behind.
People are now generally familiar with two major cannabinoids:
Both are derived from cannabis plants. However, these are only two out of an estimated 125 identified cannabinoids (plant chemicals) within cannabis. That’s a lot.
In this video, we’ll discuss CBDV vs CBD to see what similarities, and differences, these cannabinoids have.
What Is CBDV?
You have probably heard about THC by now – the psychoactive compound of the cannabis plant. THC is one of several cannabinoids located within the cannabis plant.
CBD, a non-psychoactive active cannabinoid, has gained popularity since hemp became decriminalized in the United States back in 2018. While these two cannabinoids remain the most popular, CBDV is following close behind. Interestingly, most people don’t know about CBDV – yet.
Cannabidivarin, or CBDV, is a cannabis-based chemical compound that shares almost the same molecular structure as CBD. The slight difference here is the propyl chain that CBDV carries.
Comparing Benefits of CBDV vs CBD
Although there is not much research on CBDV, the little that exists looks promising. Scientists claim that CBDV has several similarities with CBD. These similarities include things such as molecular structure and non-psychoactive properties.
Most of the research based on cannabinoids has centered around CBD as a primary focus, claiming some of the following benefits of this non-intoxicating cannabinoid:
Each compound of the cannabis plant has their own unique identity. Remember, research on CBDV is limited, however, we can reference some studies on its’ anti-seizure properties and anti-nausea effects.
CBDV as an Anti-Convulsant
CBDV shares many similar health benefits with CBD; however, it has some superior elements. Cannabidivarin (CBDV) is gaining popularity as an anti-convulsant and can be found helpful in seizure management.
A study made in 2013 on animal models showed that anticonvulsant results of CBDV potentially decrease pentylenetetrazol (PTZ)-induced seizure severity.
According to the Centers for Disease Control and Prevention (CDC) report, the number of epilepsy patients is increasing in the U.S, and there are almost 30 different types of seizures that some people must endure. As more research goes into CBDV as an anti-convulsant, hopefully, some of this will help those who suffer from seizures.
The pharmaceutical industry’s scientists and big pharma giants are currently centering CBDV’s anti-convulsant effects on their research. A British company named GW Pharmaceuticals has the license of developing CBDV medicine for epilepsy. The company mainly makes cannabis-based medicines and has demonstrated with this step that they have enough evidence to begin using CBDV in its medicinal development.
CBDV as an Anti-Nausea Remedy
A study made in 2014 to further research the anti-convulsant properties of CBDV demonstrated that CBDV and CBD might serve as a treatment for neuronal hyperexcitability (enhanced pain transmission in the spinal cord, typically after a spinal cord injury).
Another research project carried out on rats to study nausea concluded that CBDV might potentially relieve nausea.
When comparing CBDV vs CBD, CBDV has the potential to rebuild bones if they break or fracture by assisting stem cells in our bodies. That almost sounds like something out of Marvel comics. Could you imagine being able to heal your bones like Wolverine? I know it’s a stretch, but it’s fun to think about!
CBDV’s potential to reduce or even fully eradicate convulsions caused by epilepsy and related symptoms remained the researchers’ primary focus.
The unique strengths of CBDV that have been found so far have bolstered this particular cannabinoid’s credibility. The future of CBDV is just around the corner.
CBDV vs CBD Differences | Conclusion
Cannabidivarin might be the next significant cannabinoid the world will witness. When dealing with CBDV vs CBD, both cannabinoids share huge similarities that could be a massive hit in the therapeutic industry. Cannabidivarin is almost identical to cannabidiol; however, some unique properties make it different and worth pursuing on its own.
CBDV seems to have great potential (so far) to treat people with neurological disorders, epilepsy, and related seizures. The anticonvulsant, antiepileptic and anti-nausea properties of CBDV are incredible but also warrants more research.